Nos publications
Mise à jour novembre 2023
Pagination
- Page précédente
- Page 6
- Page suivante
Title | Authors | Year Trier par ordre décroissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
FcgRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia | Nazi I, Arnold DM, Smith JW, Horsewood P, Moore JC, Warkentin TE, Crowther MA, Kelton JG | 2013 | J Thromb Haemost | View FcgRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia | Researchers | Basic research |
Co-stimulation with LPS or Poly I:C markedly enhances the anti-platelet immune response and severity of fetal and neonatal alloimmune thrombocytopenia | Li C, Chen P, Vadasz B, Ma L, Zhou H, Lang S, Freedman J, Ni H | 2013 | Thromb Haemost | View Co-stimulation with LPS or Poly I:C markedly enhances the anti-platelet immune response and severity of fetal and neonatal alloimmune thrombocytopenia | Researchers | Basic research |
Quality of red blood cells washed using the ACP 215 cell processor: assessment of optimal pre- and postwash storage times and conditions | Hansen A, Yi QL, Acker JP | 2013 | Transfusion | View Quality of red blood cells washed using the ACP 215 cell processor: assessment of optimal pre- and postwash storage times and conditions | Researchers | New or improved product or process |
Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness | Arnold DM, Lauzier F, Rabbat C, Zytaruk N, Barlow Cash B, Clarke F, Heels-Ansdell D, Guyatt G, Walter SD, Davies A, Cook DJ, PROTECT Investigators on behalf of the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Clinical Trials Group | 2013 | Thromb Res | View Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness | Researchers | Clinical research |
Challenges in the management of the blood supply | Williamson LM, Devine DV | 2013 | Lancet | View Challenges in the management of the blood supply | Blood operators | Other |
Fusion of the C-terminal triskaidecapeptide of hirudin variant 3 to alpha1-proteinase inhibitor M358R increases the serpin-mediated rate of thrombin inhibition | Roddick LA, Bhakta V, Sheffield W | 2013 | BMC Biochem | View Fusion of the C-terminal triskaidecapeptide of hirudin variant 3 to alpha1-proteinase inhibitor M358R increases the serpin-mediated rate of thrombin inhibition | Researchers | Basic research |
Legal Aspects of the Blood System in Canada | Reis NM | 2013 | Public Health Law and Policy in Canada | View Legal Aspects of the Blood System in Canada | Other | Other |
A case of vertical transmission of Chagas Disease contracted via blood transfusion in Canada | Fearon MA, Scalia V, Huang M, Dines I, Ndao M | 2013 | Can J Infect Dis Med Microbiol | View A case of vertical transmission of Chagas Disease contracted via blood transfusion in Canada | Health care providers | Clinical research |
Positioning new treatments in the management of immune thrombocytopenia | Arnold DM | 2013 | Pediatr Blood Cancer | View Positioning new treatments in the management of immune thrombocytopenia | Researchers | Clinical research |
Amelioration of Murine Passive Immune Thrombocytopenia by IVIg and a Therapeutic Monoclonal CD44 Antibody Does Not Require the Myd88 Signaling Pathway | Crow AR, Yu H, Han D, Lazarus AH | 2013 | PLoS One | View Amelioration of Murine Passive Immune Thrombocytopenia by IVIg and a Therapeutic Monoclonal CD44 Antibody Does Not Require the Myd88 Signaling Pathway | Researchers | Basic research |
Donor hemovigilance | Goldman M | 2013 | Blood Transfus | View Donor hemovigilance | Health care providers | Other |
Expert approaches to common bleeding and thrombotic problems, part II | Hayward CP, Webert KE | 2013 | Semin Thromb Hemost | View Expert approaches to common bleeding and thrombotic problems, part II | Health care providers | Other |
Research with Blood Donated to Blood Banking Organizations | Reis NM | 2013 | Health Law Review | View Research with Blood Donated to Blood Banking Organizations | Other | Other |
Utility of cross-matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review | Vassallo RR, Fung M, Rebulla P, Duquesnoy R, Saw CL, Slichter SJ, Tanael S, Shehata N, International Collaboration for Guideline Development Implementation Evaluation for Transfusion Therapies Collaborators | 2013 | Transfusion | View Utility of cross-matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review | Researchers | Clinical research |
A platelet cover-up | Arnold DM | 2013 | Blood | View A platelet cover-up | Researchers | Other |
Legal Foundations of Public Health Law | Reis NM | 2013 | Public Health Law and Policy in Canada | View Legal Foundations of Public Health Law | Other | Other |
Phospholipidomics reveals differences in glycerophosphoserine profiles of hypothermically stored red blood cells and microvesicles | Bicalho B, Holovati JL, Acker JP | 2013 | Biochim Biophys Acta | View Phospholipidomics reveals differences in glycerophosphoserine profiles of hypothermically stored red blood cells and microvesicles | Researchers | Basic research |
The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand | Boyle AJ, Roddick LA, Bhakta V, Lambourne MD, Junop MS, Liaw PC, Weitz JI, Sheffield WP | 2013 | BMC Biochem | View The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand | Researchers | Basic research |
Alloimmunization of patients by blood units harboring distinct DEL variants | St-Louis M, Lebrun A, Goldman M, Lavoie M | 2013 | Immunohematology | View Alloimmunization of patients by blood units harboring distinct DEL variants | Health care providers | Clinical research |
Fc-independent phagocytosis: Implications for IVIG and other therapies in immune-mediated thrombocytopenia | Li J, van der Wal DE, Zhu L, Vadasz B, Simpson EK, Li C, Webster ML, Zhu G, Lang S, Chen P, Zeng Q, Ni H | 2013 | Cardiovasc Hematol Disord Drug Targets | View Fc-independent phagocytosis: Implications for IVIG and other therapies in immune-mediated thrombocytopenia | Researchers | Other |
Identifying D-positive donors using a second automated testing platform | Goldman M, Resz I, Cote J, Ochoa G, Angus N | 2013 | Immunohematology | View Identifying D-positive donors using a second automated testing platform | Blood operators | New or improved product or process |
Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment | Schubert P, Coupland D, Culibrk B, Goodrich RP, Devine DV | 2013 | Transfusion | View Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment | Researchers | Basic research |
CD4+ T-cells are unable to express the HIV natural resistance factor globotriosylceramide | Kim M, Binnington B, Sakac D, Lingwood CA, Branch DR | 2013 | AIDS | View CD4+ T-cells are unable to express the HIV natural resistance factor globotriosylceramide | Researchers | Basic research |
Developing highly active small molecule ice recrystallization inhibitors based upon C-linked antifreeze glycoprotein analogues | Trant JF, Briggs RA, Capicciotti C, Ben RN | 2013 | RSC Adv | View Developing highly active small molecule ice recrystallization inhibitors based upon C-linked antifreeze glycoprotein analogues | Researchers | Basic research |
ResearchUnit: Should patients receive HLA-selected platelets? | Shehata N | 2013 | Blood.ca website | View ResearchUnit: Should patients receive HLA-selected platelets? | Other | Other |
Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions | Tinmouth A, Thompson T, Arnold DM, Callum JL, Gagliardi K, Lauzon D, Owens W, Pinkerton P | 2013 | Transfusion | View Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions | Health care providers | Benchmarking and standard setting |
Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol) | Estcourt LJ, Stanworth S, Doree C, Trivella M, Hopewell S, Murphy MF, Tinmouth A | 2014 | Cochrane Database Syst Rev | View Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol) | Researchers | Clinical research |
Vitamin D and kidney transplant outcomes: a protocol for a systematic review and meta-analysis | Hesketh CC, Knoll GA, Molnar AO, Tsampalieros A, Zimmerman DL | 2014 | Syst Rev | View Vitamin D and kidney transplant outcomes: a protocol for a systematic review and meta-analysis | Researchers | Clinical research |
A thermoreversible poly(choline phosphate) based universal biomembrane adhesive | Yu X, Yang X, Horte S, Kizhakkedathu JN, Brooks DE | 2014 | Macromol Biosci | View A thermoreversible poly(choline phosphate) based universal biomembrane adhesive | Researchers | Basic research |
Does intravenous contrast-enhanced computed tomography cause acute kidney injury? Protocol of a systematic review of the evidence | Kayibanda JF, Hiremath S, Knoll GA, Fergusson D, Chow BJ, Shabana W, Akbari A | 2014 | Syst Rev | View Does intravenous contrast-enhanced computed tomography cause acute kidney injury? Protocol of a systematic review of the evidence | Researchers | Clinical research |
Evaluation of a universal point-of-issue assay for bacterial detection in buffy coat platelet components | Ramirez-Arcos S, Kou Y, Perkins H | 2014 | Vox Sang | View Evaluation of a universal point-of-issue assay for bacterial detection in buffy coat platelet components | Blood operators | New or improved product or process |
Feasibility and transport of packed red blood cells into Special Forces operational conditions | Boscarino C, Tien H, Acker J, Callum J, Hansen AL, Engels P, Glassberg E, Nathens A, Beckett A | 2014 | J Trauma Acute Care Surg | View Feasibility and transport of packed red blood cells into Special Forces operational conditions | Other | New or improved product or process |
Reference intervals of complete blood count constituents are highly correlated to waist circumference: Should obese patients have their own “normal values?†| Vuong J, Qiu Y, La M, Clarke G, Swinkels DW, Cembrowski G | 2014 | Am J Hematol | View Reference intervals of complete blood count constituents are highly correlated to waist circumference: Should obese patients have their own “normal values?†| Health care providers | Clinical research |
ResearchUnit: A Sweet Solution for Infant Transfusions? | Acker JP | 2014 | Blood.ca website | View ResearchUnit: A Sweet Solution for Infant Transfusions? | Other | Other |
Risks, benefits and the role of stakeholders in pathogen reduction technology | Newbold KB, Heddle NM, Lane SJ, Arnold E, Eyles J, Webert K | 2014 | Health Risk Soc | View Risks, benefits and the role of stakeholders in pathogen reduction technology | Other | Other |
The transcription factor Miz-1 is required for embryonic and stress-induced erythropoiesis but dispensable for adult erythropoiesis | Kosan C, Rashkovan M, Ross J, Schaffer AM, Saba I, Lemsaddek W, Trudel M, Moroy T | 2014 | Am J Blood Res | View The transcription factor Miz-1 is required for embryonic and stress-induced erythropoiesis but dispensable for adult erythropoiesis | Researchers | Basic research |
A quality monitoring program for red blood cell components: in vitro quality indicators before and after implementation of semiautomated processing | Acker JP, Hansen AL, Kurach JD, Turner TR, Croteau I, Jenkins C | 2014 | Transfusion | View A quality monitoring program for red blood cell components: in vitro quality indicators before and after implementation of semiautomated processing | Blood operators | Benchmarking and standard setting |
Prophylactic platelet transfusions: should they be a treatment of the past? | Zeller MP, Al-Habsi KS, Heddle NM | 2014 | Curr Opin Hematol | View Prophylactic platelet transfusions: should they be a treatment of the past? | Health care providers | Clinical research |
Successful treatment with oseltamivir phosphate in a patient with chronic immune thrombocytopenia positive for anti-GPIb/IX autoantibody | Shao L, Wu Y, Zhou H, Qin P, Ni H, Peng J, Hou M | 2014 | Platelets | View Successful treatment with oseltamivir phosphate in a patient with chronic immune thrombocytopenia positive for anti-GPIb/IX autoantibody | Health care providers | Clinical research |
Alpha-1 Acid Glycoprotein Reduces Hepatic Leukocyte Recruitment in Murine Models of Either Early Endotoxemia or Early Sepsis | McCurdy TR, Patrick AL, Eltringham-Smith LJ, Bhakta V, Sheffield WP, Fox-Robichaud AE | 2014 | Microcirculation | View Alpha-1 Acid Glycoprotein Reduces Hepatic Leukocyte Recruitment in Murine Models of Either Early Endotoxemia or Early Sepsis | Researchers | Basic research |
Design, implementation, and evaluation of a knowledge translation intervention to increase organ donation after cardiocirculatory death in Canada: a study protocol | Squires JE, Grimshaw JM, Taljaard M, Linklater S, Chasse M, Shemie SD, Knoll GA | 2014 | Implement Sci | View Design, implementation, and evaluation of a knowledge translation intervention to increase organ donation after cardiocirculatory death in Canada: a study protocol | Researchers | Other |
Migration, proliferation and differentiation of cord blood mesenchymal stromal cells treated with histone deacetylase inhibitor valproic acid | Marquez-Curtis LA, Qiu Y, Xu A, Janowska-Wieczorek A | 2014 | Stem Cells Int | View Migration, proliferation and differentiation of cord blood mesenchymal stromal cells treated with histone deacetylase inhibitor valproic acid | Researchers | Basic research |
ResearchUnit: Pathogen Inactivation for Safer Blood Transfusion: What are the Limitations? | Schubert P | 2014 | Blood.ca website | View ResearchUnit: Pathogen Inactivation for Safer Blood Transfusion: What are the Limitations? | Other | Other |
An epidemiologic cohort study reviewing the practice of blood product transfusions among a population of pediatric oncology patients | Lieberman L, Liu Y, Portwine C, Barty RL, Heddle NM | 2014 | Transfusion | View An epidemiologic cohort study reviewing the practice of blood product transfusions among a population of pediatric oncology patients | Health care providers | Clinical research |
Enhanced Pathogenicity of biofilm-negative Staphylococcus epidermidis isolated from platelet preparations | Hodgson SD, Greco-Stewart V, Jimenez CS, Sifri CD, Brassinga AKC, Ramirez-Arcos S | 2014 | Transfusion | View Enhanced Pathogenicity of biofilm-negative Staphylococcus epidermidis isolated from platelet preparations | Blood operators | Basic research |
Stability of relevant plasma protein activities in cryosupernatant plasma units during refrigerated storage for up to 5 days postthaw | Bhakta V, Jenkins C, Ramirez-Arcos S, Sheffield WP | 2014 | Transfusion | View Stability of relevant plasma protein activities in cryosupernatant plasma units during refrigerated storage for up to 5 days postthaw | Blood operators | New or improved product or process |
Autologous stem cell transplantation for stiff person syndrome: two cases from the Ottawa blood and marrow transplant program | Sanders S, Bredeson C, Pringle CE, Martin L, Allan D, Bence-Bruckler I, Hamelin L, Hopkins HS, Sabloff M, Sheppard D, Tay J, Huebsch L, Atkins HL | 2014 | JAMA Neurol | View Autologous stem cell transplantation for stiff person syndrome: two cases from the Ottawa blood and marrow transplant program | Health care providers | Clinical research |
Levofloxacin for BK virus prophylaxis following kidney transplantation: a randomized clinical trial | Knoll GA, Humar A, Fergusson D, Johnston O, House AA, Kim SJ, Ramsay T, Chasse M, Pang X, Zaltzman J, Cockfield S, Cantarovich M, Karpinski M, Lebel L, Gill JS | 2014 | JAMA | View Levofloxacin for BK virus prophylaxis following kidney transplantation: a randomized clinical trial | Health care providers | Clinical research |
Osmotic parameters of red blood cells from umbilical cord blood | Zhurova M, McGann LE, Acker JP | 2014 | Cryobiology | View Osmotic parameters of red blood cells from umbilical cord blood | Researchers | Basic research |
Physician registration for deceased organ donation | Li AH, Dixon S, Prakash V, Kim SJ, Knoll GA, Lam NN, Garg AX | 2014 | JAMA | View Physician registration for deceased organ donation | Health care providers | Other |